Michael Fons

Corporate Officer/Principal chez University of Texas Medical Branch

64 ans

Health Technology

Consumer Services

Postes actifs de Michael Fons

Sociétés	Poste	Début	Fin
University of Texas Medical Branch	Corporate Officer/Principal	-	-

Sociétés	Poste	Début	Fin
Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	Corporate Officer/Principal	01/01/2004	01/01/2004
INOVIO PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/06/2004	-

Internationale

Etats-Unis

Opérationnelle

Corporate Officer/Principal

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
INOVIO PHARMACEUTICALS, INC.	Health Technology

Entreprise privées	1
Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	Health Technology

Entreprise privées

Health Technology